Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation

Phyllis Wachsberger(Thomas Jefferson University), Adam P. Dicker(Thomas Jefferson University)
Frontiers in Oncology
January 1, 2013
Cited by 15


Related Papers